Isoniazid hair drug levels among TB patients as a tool to monitor adherence, exposure, and TB treatment outcomes and its acceptability in a multicultural setting. A narrative review.

Autor: Muzanyi G; Department of Pharmacology and Therapeutics, Makerere College of Health Sciences.; Uganda-Case Western Reserve University Research Collaboration., Ntale M; Department of Chemistry, College of Natural Sciences, Makerere University., Salata R; Uganda-Case Western Reserve University Research Collaboration.; Case Western Reserve University, Cleveland Ohio., Joloba M; Uganda-Case Western Reserve University Research Collaboration.; Makerere University School of Biomedical Sciences., Mukonzo J; Department of Pharmacology and Therapeutics, Makerere College of Health Sciences., Mafigiri D; Uganda-Case Western Reserve University Research Collaboration.; Makerere University School of Social Sciences., Mubiri P; Makerere University School of Public Health., Bbosa G; Department of Pharmacology and Therapeutics, Makerere College of Health Sciences.

Publikováno v: African health sciences [Afr Health Sci] 2023 Dec; Vol. 23 (4), pp. 28-34.

Preferred techniques of hair harvest for medical testing among adult pulmonary TB patients.

Autor: Muzanyi G; Department of Pharmacology and Therapeutics, Makerere College of Health Sciences.; Uganda-Case Western Reserve University Research Collaboration., Mafigiri DK; Uganda-Case Western Reserve University Research Collaboration.; Makerere University School of Social Sciences., Salata R; Uganda-Case Western Reserve University Research Collaboration.; Case Western Reserve University, Cleveland Ohio., Joloba M; Uganda-Case Western Reserve University Research Collaboration.; Makerere University School of Biomedical Sciences., Mukonzo J; Department of Pharmacology and Therapeutics, Makerere College of Health Sciences., Ntale M; Department of Chemistry, College of Natural Sciences, Makerere University., Mubiri P; Makerere University School of Public Health., Bbosa G; Department of Pharmacology and Therapeutics, Makerere College of Health Sciences.

Publikováno v: African health sciences [Afr Health Sci] 2023 Dec; Vol. 23 (4), pp. 35-41.

Rifapentine With and Without Moxifloxacin for Pulmonary Tuberculosis in People With Human Immunodeficiency Virus (S31/A5349).

Autor: Pettit AC; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Phillips PPJ; UCSF Center for Tuberculosis, University of California San Francisco, San Francisco, California, USA., Kurbatova E; Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Vernon A; Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Nahid P; UCSF Center for Tuberculosis, University of California San Francisco, San Francisco, California, USA., Dawson R; Center for TB Research Innovation, University of Cape Town Lung Institute, Cape Town, South Africa., Dooley KE; Department of Medicine, Johns Hopkins University, Baltimore, Maryland, USA., Sanne I; Clinical HIV Research Unit, University of Witwatersrand, Johannesburg, South Africa., Waja Z; Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa., Mohapi L; Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa., Podany AT; Department of Pharmacy Practice and Science, University of Nebraska Medical Center, Omaha, Nebraska, USA., Samaneka W; Department of Medicine, University of Zimbabwe College of Health Sciences, Harare, Zimbabwe., Savic RM; UCSF Center for Tuberculosis, University of California San Francisco, San Francisco, California, USA., Johnson JL; Tuberculosis Research Unit, University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.; Uganda-Case Western Reserve University Research Collaboration, Kampala, Uganda., Muzanyi G; Uganda-Case Western Reserve University Research Collaboration, Kampala, Uganda., Lalloo UG; Enhancing Care Foundation, Durban University of Technology, Durban, South Africa., Bryant K; Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Sizemore E; Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Scott N; Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Dorman SE; Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA., Chaisson RE; Department of Medicine, Johns Hopkins University, Baltimore, Maryland, USA., Swindells S; Department of Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA.

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2023 Feb 08; Vol. 76 (3), pp. e580-e589.

The threat of persistent bacteria and fungi contamination in tuberculosis sputum cultures.

Autor: Muzanyi G; Uganda-Case Research Collaboration., Peace A; Uganda-Case Research Collaboration., Wamuntu B; Uganda-Case Research Collaboration., Joseph A; Joint Clinical Research Center., Nassali J; Uganda-Case Research Collaboration.

Publikováno v: African health sciences [Afr Health Sci] 2021 Jun; Vol. 21 (2), pp. 628-632.

Recommendations for developing accessible patient information leaflets for clinical trials to address English language literacy as a barrier to research participation.

Autor: Wylde, Vikki^1,2 (AUTHOR) v.wylde@bristol.ac.uk, Brennan, Sharon³ (AUTHOR), Johnson, Emma¹ (AUTHOR), Roberts, Kirsty⁴ (AUTHOR), Beswick, Andrew D.^1,2 (AUTHOR), Jameson, Catherine^1,2 (AUTHOR)

Publikováno v: Trials. 9/27/2024, Vol. 25 Issue 1, p1-16. 16p.